1315 Capital

1315 Capital, founded in 2014 and based in Philadelphia, Pennsylvania, specializes in providing expansion and growth capital to commercial-stage companies in the specialty pharmaceutical, medical technology, and healthcare services sectors. The firm focuses on businesses that aim to improve cost containment and leverage digital health innovations. With a target investment range of $10 to $20 million, 1315 Capital seeks to support healthcare entities that have the potential to scale their revenue to approximately $100 million, positioning them for acquisition or entry into public markets. The firm's strategy is rooted in identifying niche market segments and partnering with high-quality management teams to facilitate rapid growth in a capital-efficient manner.

Jordan Brown

Principal

Edward Chan

Partner

Carter Cortazzi

Associate and Investment Team Member

Michael Koby

Co-Founder and Partner

Ryan Kraus

Vice President

Ian Li

Principal

Craig Matturro

Principal

Adele C. Oliva

Founding Partner

Matthew Q Reber

Partner

16 past transactions

SciSafe

Acquisition in 2024
SciSafe, Inc. is a biotechnology company that specializes in the storage of pharmaceutical and biological samples. Founded in 2010 and based in Cranbury, New Jersey, with an additional office in Billerica, Massachusetts, SciSafe provides a range of services including biological storage, pharmaceutical stability testing, and cold chain logistics. The company offers advanced storage conditions such as refrigerated, frozen, ultra-low, and cryogenic environments, catering to needs such as vaccine storage, clinical trial sample retention, and bulk pharmaceutical storage. With a focus on specimen management, SciSafe ensures clients have comprehensive control over their samples throughout the storage process. The company's experienced personnel, with over 60 years of combined expertise in life sciences, are dedicated to meeting the stringent requirements of its clients in specimen storage and cold chain management. As of October 2020, SciSafe operates as a subsidiary of BioLife Solutions, Inc.

Experic

Venture Round in 2024
Experic is a contract development and manufacturing organization (CDMO) that offers comprehensive pharmaceutical supply services throughout the entire product life cycle, from clinical trials to commercial production. The company specializes in various dosing and packaging formats, including capsule filling, powder and pellet dosing, and assembly of autoinjectors and pen devices. Experic utilizes advanced Harro Höfliger equipment within a state-of-the-art Class A GMP facility to ensure the highest quality standards, even for expedited projects. Its services encompass process development, analytical support, clinical trial supply, vendor management, packaging, and logistics, all delivered with a personalized approach to meet the specific needs of its clients.

Spineology

Series A in 2024
Spineology Inc. is a medical technology company that specializes in anatomy-conserving solutions for spine surgery. Founded in 1996 and based in Saint Paul, Minnesota, the company offers a range of products including pedicular fixation systems such as Threshold and Fortress, spinal fixation systems like CapLOX II, and biological products including Prime, a liquid tissue matrix, and Armor, an allograft for wound covering. Their portfolio also features interbody fusion systems like Rampart O and Rampart T, as well as instruments for facet fixation, spinous process fixation, and retraction systems such as Medius and SOAR. Additionally, Spineology provides ProMap, an EMG navigation system, and OptiMesh, a graft containment solution. The company’s innovations enable healthcare professionals to perform minimally invasive surgeries, enhancing procedural efficiency and improving patient recovery outcomes.

NutriSense

Series A in 2022
NutriSense, Inc. is a health and wellness platform that specializes in monitoring blood glucose levels in real-time using continuous glucose monitoring (CGM) technology and a dedicated tracking application. Founded in 2019 and based in Chicago, Illinois, the company focuses on personalizing nutrition through advanced machine learning techniques. NutriSense offers corporate wellness programs, along with a glucose sensor and app for diet tracking, as well as access to personal dietitians. The company's mission is to empower individuals to discover and achieve their health potential by providing tailored insights into their nutritional habits.

Homestead Smart Health Plans

Acquisition in 2021
Homestead Smart Health Plans specializes in offering health plans to self-funded employer groups, focusing on creating transparent and sustainable health benefit solutions. The company utilizes a reference-based repricing system to structure its plans, which are designed to help employers manage healthcare expenses effectively. In addition to providing third-party administration services, Homestead Smart Health Plans includes stop-loss insurance protection to safeguard against significant financial losses. This approach enables employers to operate as self-funded entities, ultimately leading to substantial savings in healthcare costs.

Onkos Surgical

Series C in 2021
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

miraDry

Acquisition in 2021
miraDry is a only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors. miraDry non-invasive procedure is safe and highly efficacious with a proven commercial and clinical track record.

Interpace Biosciences

Post in 2020
Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

Encore Dermatology

Debt Financing in 2019
Encore Dermatology is a privately held, fully-integrated dermatology company based in Malvern, Pennsylvania, established in 2015. The company specializes in delivering prescription therapies and medical devices to dermatologists, focusing on a variety of medical dermatology products. These offerings address several topical disease states, including conditions like acne and atopic dermatitis, thereby facilitating enhanced skincare and treatment options for patients. Through its comprehensive approach, Encore Dermatology aims to improve patient outcomes and streamline the dermatological care process.

Biocoat

Acquisition in 2019
Biocoat is a developer and manufacturer of specialized biomaterial coatings for medical devices, focusing on custom-engineered solutions that meet specific client requirements. The company is particularly known for its hydrophilic coatings, which are designed to be lubricious, abrasion-resistant, non-thrombogenic, and biocompatible. These coatings enhance the performance of various medical devices, such as vascular catheters and guide wires, by minimizing friction and facilitating smoother movement through the body. Biocoat's innovative products aim to improve the safety and effectiveness of medical interventions.

Centurion Service Group

Acquisition in 2018
Centurion Service Group, LLC is a leading used medical equipment auction house based in Franklin Park, Illinois, with additional locations in Chicago, Las Vegas, South Florida, Dallas, Columbus, and Salt Lake City. Established in 2001, the company specializes in the sale of a wide variety of medical equipment, including radiology machines, MRI and CT machines, and surgical instruments. Centurion facilitates the buying and selling of surplus medical equipment for healthcare facilities, providing services such as certified appraisals, asset inventory management, and equipment relocation. With a robust auction platform, it sells over 8,000 pieces of medical equipment monthly, serving as a comprehensive source for healthcare providers seeking both refurbished and used equipment. By partnering with hospitals and surgery centers, Centurion helps unlock the value of unused medical assets, thereby enhancing financial resources for its clients.

Misonix

Post in 2017
Misonix is a leading medical device company specializing in ultrasonic surgical technology. The company designs, manufactures, and markets innovative devices that enhance clinical outcomes in various surgical fields, including neurosurgery, orthopedic surgery, plastic surgery, and wound care. Misonix's product portfolio features advanced ultrasonic platforms such as aspirators for soft and hard tissue removal, instruments for laparoscopic procedures, and devices for wound cleansing and debridement. Additionally, its offerings include tools for precision bone cutting and sculpting, as well as liposuction instruments aimed at improving body aesthetics. Notable products include BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. Misonix serves a global market, with a presence in regions such as the United States and the United Kingdom, contributing to the overall value of the healthcare system.

Colorescience

Series C in 2017
Colorescience, Inc. is a skincare brand based in Carlsbad, California, specializing in mineral-based cosmetics and sunscreen products. Founded in 2000, the company offers a range of items, including treatment products, UV protectors, primers, foundations, and enhancers, designed to address various skin concerns such as pigmentation, redness, dark circles, and signs of aging. Colorescience emphasizes high-quality, dermatologist-recommended formulations that incorporate minerals, antioxidants, and botanicals to promote healthy skin and protect against sun damage. The brand markets its products through a network of licensed physicians, luxury spas, retailers, and online platforms, aiming to stand out in the aesthetic makeup segment by providing effective and easy-to-use solutions for diverse skin types.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

JDS Therapeutics

Private Equity Round in 2015
JDS Therapeutics, LLC, founded in 2011 and headquartered in Purchase, New York, specializes in developing and marketing healthcare products tailored for physicians and healthcare networks. The company focuses on nutritional ingredients and pharmacological solutions addressing diabetes, women's health, cardiovascular diseases, and weight management. Its product lineup includes ZERAMAX, a medical food designed for diabetes management; JDS-CR-002, an oral prescription drug; JDS-CR-102, an injectable prescription drug; JDS-SI-002, a medical food for osteoporosis; and JDS-CR-007, a nutritional supplement aimed at alleviating hot flashes. Additionally, JDS Therapeutics is engaged in the development and commercialization of natural, bioactive compounds and holds over 100 issued and pending patents.

Onkos Surgical

Series A in 2015
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.